Xencor
IPODesigning Proteins Delivering Medicines™
Public · Pasadena, United States · Founded 1997 · $75.1M raised
- Headquarters
- Pasadena, California
- Employees
- 201–500
- Founded
- 1997
- Business Model
- B2B
- Website
- xencor.com
- Total Funding
- $75.1M
- Last Round
- $10.0M Series AJun 2013
- Rounds
- 5
- Type
- Public
About
Clinical-stage biopharmaceutical company developing XmAb-engineered antibodies and cytokines to treat cancer and autoimmune diseases.
Summary
Xencor is a Biotech company based in Pasadena, United States, founded in 1997. It has raised $75.1M in total across 5 rounds, most recently a $10.0M Series A round in Jun 2013. Investors include Moore Capital and Stafford Capital Partners.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2013
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...